The present invention relates to a pharmaceutical composition for preventing or treating diabetic complications. A Stranvaesia davidiana extract or a fraction thereof can be used for preventing or treating diabetic complications, such as diabetic retinopathy or diabetic nephropathy, by effectively inhibiting vasodilation or vascular hyperplasia in animal diabetes model tests.